Koninklijke Philips (RYLPF) Income from Continuing Operations (2009 - 2026)

Koninklijke Philips (RYLPF) recorded quarterly Income from Continuing Operations of 273954482.12 in Q1 2026, up 27.91% quarter-over-quarter from 214184006.7 in Q4 2025, and up 98.81% on a YoY basis from 137796861.58 in Q1 2025.

Koninklijke Philips (RYLPF) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Koninklijke Philips' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 273954482.12 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 98.81% year-over-year to 273954482.12; the TTM figure through Mar 2026 stood at 1518066824.66 (up 11459.7% YoY), while the FY2025 annual figure was 1047639163.23, up 216.71% from the prior year.
  • Income from Continuing Operations was 273954482.12 for Q1 2026 at Koninklijke Philips, up from 214184006.7 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1077964463.87 in Q2 2024 to a low of 1732215298.56 in Q3 2022.
  • Historically, Income from Continuing Operations has averaged 259283448.44 across 5 years, with a median of 294322826.69 in 2024.
  • The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations sank 729.82% in 2022, then soared 285.03% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 108146220.72 in 2022, then tumbled by 495.94% to 644488005.48 in 2023, then tumbled by 40.93% to 908306090.14 in 2024, then surged by 123.58% to 214184006.7 in 2025, then grew by 27.91% to 273954482.12 in 2026.
  • The last three Income from Continuing Operations figures came in at 273954482.12 (Q1 2026), 214184006.7 (Q4 2025), and 423197943.07 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 220.30 Mn
10 Koninklijke Philips - - 2.07 Bn 273.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 273.95 Mn
Dec 31, 2025 214.18 Mn
Sep 30, 2025 423.20 Mn
Jun 30, 2025 606.73 Mn
Mar 31, 2025 137.80 Mn
Dec 31, 2024 -908.31 Mn
Sep 30, 2024 -294.32 Mn
Jun 30, 2024 1.08 Bn
Mar 31, 2024 -1.09 Bn
Dec 31, 2023 -644.49 Mn
Sep 30, 2023 -435.44 Mn
Jun 30, 2023 -582.57 Mn
Mar 31, 2023 -743.83 Mn
Dec 31, 2022 -108.15 Mn
Sep 30, 2022 -1.73 Bn
Jun 30, 2022 -280.64 Mn
Mar 31, 2022 -320.99 Mn
Dec 31, 2021 145.28 Mn
Sep 30, 2021 334.92 Mn
Jun 30, 2021 44.56 Mn